Accuray Inc
NASDAQ:ARAY
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.41
3.01
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ARAY stock under the Base Case scenario is 3.98 USD. Compared to the current market price of 1.8 USD, Accuray Inc is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Accuray Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ARAY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Accuray Inc
Balance Sheet Decomposition
Accuray Inc
Current Assets | 323.2m |
Cash & Short-Term Investments | 68.6m |
Receivables | 92m |
Other Current Assets | 162.7m |
Non-Current Assets | 145.4m |
Long-Term Investments | 9.8m |
PP&E | 58.5m |
Intangibles | 57.7m |
Other Non-Current Assets | 19.3m |
Current Liabilities | 195.3m |
Accounts Payable | 50m |
Accrued Liabilities | 51.9m |
Other Current Liabilities | 93.4m |
Non-Current Liabilities | 228.3m |
Long-Term Debt | 164.4m |
Other Non-Current Liabilities | 63.9m |
Earnings Waterfall
Accuray Inc
Revenue
|
446.6m
USD
|
Cost of Revenue
|
-303.4m
USD
|
Gross Profit
|
143.1m
USD
|
Operating Expenses
|
-140m
USD
|
Operating Income
|
3.1m
USD
|
Other Expenses
|
-18.6m
USD
|
Net Income
|
-15.5m
USD
|
Free Cash Flow Analysis
Accuray Inc
USD | |
Free Cash Flow | USD |
In its strongest revenue quarter ever, Accuray reported $134 million in Q4 2024, a 14% year-over-year increase driven by a record number of system shipments and robust international demand. Total annual revenue was $447 million, flat from the previous year, but notable gains were seen internationally, particularly with 80% of revenue coming from markets outside the U.S. The company anticipates growth in these regions to continue, while a cautious recovery in the U.S. is expected in the latter half of FY 2025. For FY 2025, Accuray guides a revenue range of $460-$470 million and adjusted EBITDA of $27.5-$29.5 million.
What is Earnings Call?
ARAY Profitability Score
Profitability Due Diligence
Accuray Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Accuray Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
ARAY Solvency Score
Solvency Due Diligence
Accuray Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Score
Accuray Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARAY Price Targets Summary
Accuray Inc
According to Wall Street analysts, the average 1-year price target for ARAY is 6.25 USD with a low forecast of 5.56 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for ARAY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ARAY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Contact
IPO
Employees
Officers
The intrinsic value of one ARAY stock under the Base Case scenario is 3.98 USD.
Compared to the current market price of 1.8 USD, Accuray Inc is Undervalued by 55%.